Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients. This Congress focuses on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics.
The NCCN 8th Annual Congress: Hematologic Malignancies™ took place September 20 – 21, 2013 in New York, NY. Accredited materials from this congress will be available shortly through the NCCN Continuing Education Portal.
Organizations who are interested in exhibiting at NCCN programs are encouraged to contact Jennifer Tredwell, Director, Marketing.
Please check back often for the most up-to-date information. Please contact 866.788.NCCN (6226) or send an e-mail if you have additional questions.